Open AccessCOVID-19 Induced Pancytopenia in a Major Molecular Response CML patient on Dasatinib: A Case Report and Review of Literature
Author(s) -
Balraj Singh,
Sarah Ayad,
Parminder Kaur,
Vinod Kumar,
Sachin Gupta,
Michael Maroules
Publication year - 2021
Publication title -
european journal of case reports in internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2284-2594
DOI - 10.12890/2021_002233
Subject(s) - pancytopenia , medicine , dasatinib , covid-19 , disease , coronavirus , pediatrics , presentation (obstetrics) , case presentation , intensive care medicine , infectious disease (medical specialty) , virology , surgery , outbreak , imatinib , bone marrow , myeloid leukemia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has caused a global health crisis. COVID-19 can have a multifaceted presentation. A wide range of complications and outcomes can emerge based on the severity and comorbidities of the infected patient. We report a 42-year-old male with past medical history of CML on Dasatinib (in Major Molecular Response) who was diagnosed with COVID-19 and developed pancytopenia. Our case and review of available reports add to the limited literature available regarding COVID-19 in CML.